Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Clinical trial NCT02016911 · COMPLETED
Trial details
- NCT number
- NCT02016911
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2015-01-12
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.